Avalo Therapeutics Names Michael Heffernan as Board Chairman

, MT Newswires -  10:18 AM ET 3/26/2025 default

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

10:18 AM EDT, 03/26/2025 (MT Newswires) -- Avalo Therapeutics ( AVTX ) said Wednesday that Michael Heffernan has been named board chairman, succeeding Garry Neil.

Neil will continue as chief executive officer and board member, the company said.

Heffernan is the founder and chairman of Collegium Pharmaceutical (COLL), where he also previously served as president and CEO, Avalo said.

Avalo shares were more than 3% higher in recent trading.

Price: 8.72, Change: +0.18, Percent Change: +2.12

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.